2BB score and signals
Nuvation Bio Inc. Class A Common Stock’s current 2BB score is 56 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 72 | High |
| Momentum | 63 | Improving |
| Financial strength | 23 | Weak |
| Quality | 96 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| CEO | David Hung |
| Founded | 2018 |
| Employees | 305 |
| 52-week range | $3.36 – $9.75 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.121 | — | $36.00M |
| 2026-08-06 | — | -0.1872 | — | $27.49M |
| 2026-05-04 | 0.01 | 0.0092 | $83.23M | $63.50M |
| 2026-03-02 | -0.11 | -0.0911 | $41.87M | $38.07M |
Related companies
2BBBullish & Bearish